Showing results (301-310 of 433) with videos related to

Sort By:
Pageof 44
Recent Patents on Cardiovascular Drug Discovery|December 24, 2013
Need for ongoing anti arrhythmic drugs after ablation of atrial fibrillation. ReviewFrancesca Salghetti, Enrico Vizzardi, Mohamed Elmaghawry, et al.
Cancer Research|December 22, 1999
Combination therapy with the farnesyl protein transferase inhibitor SCH66336 and SCH58500 (p53 adenovirus) in preclinical cancer modelsL L Nielsen, B Shi, G Hajian, et al.
Nutrients|April 12, 2022
Role of Zinc in Diabetic Kidney DiseaseGuido Gembillo, Luca Visconti, Alfio Edoardo Giuffrida, et al.
Bioengineering (Basel, Switzerland)|December 23, 2022
A Novel Smart Belt for Anxiety Detection, Classification, and Reduction Using IIoMT on Students' Cardiac Signal and MSYRishi Pal, Deepak Adhikari, Md Belal Bin Heyat, et al.
Journal of the American Society of Nephrology : JASN|May 23, 2003
A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survivalNicola Tessitore, Giancarlo Mansueto, Valeria Bedogna, et al.
Cells|March 29, 2023
Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced DyskinesiaCarla Budrow, Kayla Elder, Michael Coyle, et al.
Journal of Medicinal Chemistry|May 29, 1992
Cyclic RGD peptide analogues as antiplatelet antithromboticsP L Barker, S Bullens, S Bunting, et al.
Children (Basel, Switzerland)|October 29, 2025
Health Profiles in Developmental Age: An Analysis of the Eating Habits and Lifestyles of a Sample of Italian ChildrenBianca Maria Bocci, Dario Lipari, Ilaria Manini, et al.
Pharmacology, Biochemistry, and Behavior|May 5, 2022
The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian ratsSophie R Cohen, Michelle L Terry, Michael Coyle, et al.
Journal of the American Pharmacists Association : Japha|July 2, 2026
Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practiceBrooke Penny, Melissa Lipari, David W Gutenschwager, et al.
Pageof 44